Associated cancers in parents and offspring of polycythaemia vera and myelofibrosis patients

British Journal of Haematology

Volumn 147, Issue 4, 2009, Pages 526-530

  Hemminki, Kari ^a,b   Sundquist, Jan ^b,c   Bermejo, Justo L ^a,d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Discordant cancers; Family history; Leukaemia; Myelofibrosis; Polycythaemia vera

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLADDER CANCER; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; COLORECTAL CANCER; CONTROLLED STUDY; ENDOCRINE TUMOR; EYE TUMOR; FAMILY HISTORY; HODGKIN DISEASE; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MYELOID METAPLASIA; NERVOUS SYSTEM TUMOR; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROGENY; PROSTATE CANCER; SIBLING; UTERINE CERVIX CANCER;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PARENTS; POLYCYTHEMIA VERA; PRIMARY MYELOFIBROSIS; REGISTRIES; RISK ASSESSMENT; SIBLINGS; SWEDEN;

EID: 70350451750     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07874.x     Document Type: Article

References (14)

1. Bellanne-Chantelot, C., Chaumarel, I., Labopin, M., Bellanger, F., Barbu, V., De Toma, C., Delhommeau, F., Casadevall, N., Vainchenker, W., Thomas, G. Najman, A. (2006) Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders. Blood, 108, 346 352.
2. Centre for Epidemiology (2007) Cancer Incidence in Sweden 2005. The National Board of Health and Welfare, Stockholm.
3. Hemminki, K. Jiang, Y. (2001) Familial polycythemia vera: results from the Swedish Family-Cancer Database. Leukemia, 16, 1313 1315. (Pubitemid 32776463)
4. Hemminki, K., Li, X., Plna, K., Granström, C. Vaittinen, P. (2001a) The nation-wide Swedish Family-Cancer Database: updated structure and familial rates. Acta Oncologica, 40, 772 777. (Pubitemid 33081988)
5. Hemminki, K., Vaittinen, P., Dong, C. Easton, D. (2001b) Sibling risks in cancer: clues to recessive or X-linked genes? British Journal of Cancer, 84, 388 391.
6. Hemminki, K., Sundquist, J. Lorenzo Bermejo, J. (2008a) Familial risks for cancer as the basis for evidence-based clinical referral and counseling. The Oncologist, 13, 239 247.
7. Hemminki, K., Zhang, H., Sundquist, J. Lorenzo Bermejo, J. (2008b) Myeloproliferative disorders in Sweden: incidence trends and multiple tumours. Leukemia Research, 33, e14 e16.
8. Jaffe, E., Harris, N., Stein, H. Vardiman, J. (2001) Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC, Lyon.
9. Landgren, O., Goldin, L.R., Kristinsson, S.Y., Helgadottir, E.A., Samuelsson, J. Bjorkholm, M. (2008) Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden. Blood, 112, 2199 2204.
10. Rumi, E. (2008) Familial chronic myeloproliferative disorders: the state of the art. Hematological Oncology, 26, 131 138.
11. Rumi, E., Passamonti, F., Della Porta, M.G., Elena, C., Arcaini, L., Vanelli, L., Del Curto, C., Pietra, D., Boveri, E., Pascutto, C., Cazzola, M. Lazzarino, M. (2007) Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation. Journal of Clinical Oncology, 25, 5630 5635.
12. Skoda, R. Prchal, J.T. (2005) Chronic myeloproliferative disorders - introduction. Seminars in Hematology, 42, 181 183.
13. Tefferi, A. Vardiman, J.W. (2008) Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia, 22, 14 22.
14. Turesson, I., Linet, M.S., Bjorkholm, M., Kristinsson, S.Y., Goldin, L.R., Caporaso, N.E. Landgren, O. (2007) Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003. International Journal of Cancer, 121, 2260 2266.